Logic,
I take supplemental B-6 & B-12 but don't worry about the other B's as I am meeting the RDA for the other B's. Is a proper balance of B important in general or just for your regime?
For a start, there is a big difference between RDA and the optimal dosages mkp6019
I need to re-investigate this subject myself but I dont have the inclination atm and dont remember all the details offhand. Probably due to a lack of B vits!
it's also somewhat of a moot point: unless you go with separate Bs, you end up taking whatever is in the multi...
The info is in the NAD+ and homocysteine threads IIRC.
Personally I think staying away from any form of B3 ending with amide is the most important thing as it downregulates SIRT etc and you get (...more than?) enough of the amidated B3 from food.
Large doses increase homocysteine.
Methyl donors, such as B12, (in the methylcobalamin form) and B6 counteract this.
So different forms have greatly different effects.
See Bentafontamine, P5P, Pyridoxamine etc.
As niacin/nicotinic acid causes a flush; good luck finding a multi that uses this non amidated form!
I have no idea why they don't use Inositol Hexanicotinate and/or Chromium polynicotinate and kill 2-3 birds with one stone.
Cost probably?
Are you sure about Niacinamide... because: http://www.life-enha...protective-role
Here is Pubmed's list of papers wit D A Sincliar's name on them:
http://www.ncbi.nlm....or_uid=12297502
Note the 1st one:
Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.
...We show that physiological concentrations of nicotinamide noncompetitively inhibit both Sir2 and SIRT1 in vitro. The degree of inhibition by nicotinamide (IC(50) < 50 microm) is equal to or better than the most effective known synthetic inhibitors of this class of proteins...
Now in your link its obvious he's aware of this paper:
"“We should entertain the possibility that nicotinamide is activating SIRT1 in vivo, not inhibiting it..."
Now the early 2002 study was in vitro, but as we are interested in the level of NAM inside the living cell, as it also is in vivo, the in vitro/vivo point is moot IMHO..?
But to fair; the in vitro study is old and a look at the newer evidence is warranted.
Anti-Aging-Firewalls does just that with their 2015 summary:
5. Nicotinamide (Nam)
Nicotinamide is a direct inhibitor of both the SIRT enzymes and the PARP enzymes.
The accumulation of excess nicotinamide in cells is probably a major cause of aging. Whereas we typically associate “NAD deficiency” with aging, “Nam excess” may have a similar effect. To no one’s surprise, the levels of the two compounds are inversely related in aging.
Nam plays a role in both aging and in disease. In hypertension and in aging individuals with normal blood pressure, Nam inhibits the methylation-mediated degradation of catecholamines. Thus Nam excess plays a role in hypertension (see references below).
Nicotinamide also has an epigenetic effect. When SIRT1 is inhibited, cells age and cancer oncogenes are re-activated. SIRT1 silences these genes by histone deacetylation of H3K9 and H4K16 residues on the histones of these oncogenes.
A recent article showed that in rats, nicotinamide supplementation during pregnancy causes global DNA hypomethylation in rat fetuses. Nicotinamide has detrimental effects in development, detrimental metabolic effects, and detrimental epigenetic effects when given to young rats. Low dose nicotinamide increased weight gain in developing rats. High dose nicotinamide did not, however. The livers of nicotinamide-fed young rats had more DNA damage (8oxoG), impaired glucose tolerance, and increased insulin resistance. Nicotinamide increased the levels of N-methylnicotinamide in the blood and decreased betaine levels in the blood. This resulted in a global hypomethylation of DNA in the rat genome. Nicotinamide also had “gene-specific effects” on CpG islands within the promoters of the following genes:
- NNMT gene – this was down-regulated
- DNMT genes – these were down-regulated
- Homocysteine metabolism genes – these were down-regulated
- Antioxidant genes and oxidative stress protection genes – these were down-regulated
Since niacin is converted into nicotinamide in human tissues, high dose niacin probably produces all of the above effects. A recent paper called niacin and nicotinic acid “methyl consumers” and strongly suggested that high niacin/nicotinic acid intake is bad.
Excess nicotinamide has also been shown to increase plasma serotonin and histamine levels in humans, due to disrupting the metabolism of these neurotransmitters. This is probably due to the fact that methyl donors and methylation enzymes are needed for serotonin/histamine metabolism. Most importantly, nicotinamide is a direct inhibitor of the Sirtuin enzymes (SIRT1-7) and the PARP enzymes (all 17 of the PARPs).
The molecular mechanism by which Nam works is very straightforward. Nam acts as a direct inhibitor of the SIRT1 enzyme pocket where NAD binds. Thus Nam is a “competitive inhibitor” of NAD and is “bad” when it comes to most cancers, aging, and most diseases.
On the other hand, inhibition of SIRT1 by Nicotinamide may be a “good thing” in the brain, where it may prevent NAD+ depletion and thereby protect neurons against excitotoxicity and neuronal cell death induced by PARP1.
As the cell consumes NAD (by SIRT1-7, PARP1, PARP2, Tankyrases, CD38, CD157, ARTs, and other enzymes), the NAD is consumed, leaving the by-product, Nam. There are two primary ways of “disposing of Nam”. They are methylation/excretion or recycling of Nam into NMN (and subsequently NAD) via the “NAD salvage cycle”.
Here are the problems with both of these methods of reducing Nam levels in the cell. (see #2 and #3 below).
References:
- 2002 Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1
- 2006 Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation
- 2009 Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger Energetically Compromised Neurons
- Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats
- 2013 Association of Nicotinamide-N-Methyltransferase Gene rs694539 Variant with Patients with Nonalcoholic Steatohepatitis
- 2013 Excess nicotinamide increases plasma serotonin and histamine levels
- 2013 Excessive nicotinic acid increases methyl consumption and hydrogen peroxide generation in rats
- 2014 Metabolism: Targeting a fat-accumulation gene
Conclusion: It is now clear that high concentrations nicotinamide are harmful to health. HIgh doses of dietary niacin probably produce the same effects, despite the many benefits of high dose niacin. With aging, nicotinamide levels already go up. Adding more nicotinamide is probably not going to “cure” aging. Adding a methyl donor to eliminate nicotinamide (such as betaine) may be a good thing.
http://www.anti-agin...life-extension/
The only fault I can find with James P Watson or Vince Giuliano's reasoning is that Niacin does not seem to have quite the same effect as Nicotinamide as it seems to feed into the de-novo NAD+ synthesis pathway, leaving NAM levels alone until after the synthesis of SIRT etc:
http://www.longecity...ndpost&p=693619
So I'm "entertaining the possibility that" the sale of Nicotinamide Riboside "is activating" Sinclair's bank balance, since that 2002 study!?
Edited by Logic, 13 February 2016 - 12:02 PM.